
Morepen Laboratories Limited has informed the Exchange regarding a press release dated November 09, 2020, titled "Morepen Labs performance catches pace in Q2 FY 2020-21 with a six-fold rise in its Net Profit led by strong API business".
Filed with NSE · · 4 pages · English
Morepen Laboratories Limited has released a press statement detailing its financial performance for the second quarter of the fiscal year, highlighting a significant increase in net profit driven by its API business. The company reported a six-fold rise in net profit, attributed to strong sales in bulk drugs and diagnostic devices, as well as a notable increase in revenue from both domestic and export markets.
Written by 6ix AI from the company’s filing. How 6ix writes summaries

Morepen Laboratories Limited has informed the Exchange regarding a press release dated November 09, 2020, titled "Morepen Labs performance catches pace in Q2 FY 2020-21 with a six-fold rise in its Net Profit led by strong API business".
Morepen Laboratories Limited on 6ix
Follow Morepen Laboratories into a list and get an email when it puts out news.
Follow Morepen Laboratories